BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17548659)

  • 1. Regulation of DMBT1 via NOD2 and TLR4 in intestinal epithelial cells modulates bacterial recognition and invasion.
    Rosenstiel P; Sina C; End C; Renner M; Lyer S; Till A; Hellmig S; Nikolaus S; Fölsch UR; Helmke B; Autschbach F; Schirmacher P; Kioschis P; Hafner M; Poustka A; Mollenhauer J; Schreiber S
    J Immunol; 2007 Jun; 178(12):8203-11. PubMed ID: 17548659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DMBT1 confers mucosal protection in vivo and a deletion variant is associated with Crohn's disease.
    Renner M; Bergmann G; Krebs I; End C; Lyer S; Hilberg F; Helmke B; Gassler N; Autschbach F; Bikker F; Strobel-Freidekind O; Gronert-Sum S; Benner A; Blaich S; Wittig R; Hudler M; Ligtenberg AJ; Madsen J; Holmskov U; Annese V; Latiano A; Schirmacher P; Amerongen AV; D'Amato M; Kioschis P; Hafner M; Poustka A; Mollenhauer J
    Gastroenterology; 2007 Nov; 133(5):1499-509. PubMed ID: 17983803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDP-Induced selective tolerance to TLR4 ligands: impairment in NOD2 mutant Crohn's disease patients.
    Cantó E; Moga E; Ricart E; Garcia-Bosch O; Garcia-Planella E; Juarez C; Vidal S
    Inflamm Bowel Dis; 2009 Nov; 15(11):1686-96. PubMed ID: 19572373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease.
    van Heel DA; Ghosh S; Hunt KA; Mathew CG; Forbes A; Jewell DP; Playford RJ
    Gut; 2005 Nov; 54(11):1553-7. PubMed ID: 15928043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nod2 improves barrier function of intestinal epithelial cells via enhancement of TLR responses.
    Hiemstra IH; Bouma G; Geerts D; Kraal G; den Haan JM
    Mol Immunol; 2012 Oct; 52(3-4):264-72. PubMed ID: 22750073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crohn's disease patients homozygous for the 3020insC NOD2 mutation have a defective NOD2/TLR4 cross-tolerance to intestinal stimuli.
    Kullberg BJ; Ferwerda G; de Jong DJ; Drenth JP; Joosten LA; Van der Meer JW; Netea MG
    Immunology; 2008 Apr; 123(4):600-5. PubMed ID: 18028374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells.
    Rosenstiel P; Fantini M; Bräutigam K; Kühbacher T; Waetzig GH; Seegert D; Schreiber S
    Gastroenterology; 2003 Apr; 124(4):1001-9. PubMed ID: 12671897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal NOD2 expression and NF-kappaB activation in pediatric Crohn's disease.
    Stronati L; Negroni A; Merola P; Pannone V; Borrelli O; Cirulli M; Annese V; Cucchiara S
    Inflamm Bowel Dis; 2008 Mar; 14(3):295-302. PubMed ID: 18092345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel crosstalk between TLR4- and NOD2-mediated signaling in the regulation of intestinal inflammation.
    Kim H; Zhao Q; Zheng H; Li X; Zhang T; Ma X
    Sci Rep; 2015 Jul; 5():12018. PubMed ID: 26153766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Cytosolic Microbial Receptor Nod2 Regulates Small Intestinal Crypt Damage and Epithelial Regeneration following T Cell-Induced Enteropathy.
    Zanello G; Goethel A; Rouquier S; Prescott D; Robertson SJ; Maisonneuve C; Streutker C; Philpott DJ; Croitoru K
    J Immunol; 2016 Jul; 197(1):345-55. PubMed ID: 27206769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal DMBT1 expression is modulated by Crohn's disease-associated IL23R variants and by a DMBT1 variant which influences binding of the transcription factors CREB1 and ATF-2.
    Diegelmann J; Czamara D; Le Bras E; Zimmermann E; Olszak T; Bedynek A; Göke B; Franke A; Glas J; Brand S
    PLoS One; 2013; 8(11):e77773. PubMed ID: 24223725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NOD2 receptors in adenopituitary folliculostellate cells: expression and function.
    Correa-de-Santana E; Fröhlich B; Labeur M; Páez-Pereda M; Theodoropoulou M; Monteserin JL; Renner U; Stalla GK
    J Endocrinol; 2009 Oct; 203(1):111-22. PubMed ID: 19608614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the NOD2 genotype with bacterial translocation via altered cell-cell contacts in Crohn's disease patients.
    Kosovac K; Brenmoehl J; Holler E; Falk W; Schoelmerich J; Hausmann M; Rogler G
    Inflamm Bowel Dis; 2010 Aug; 16(8):1311-21. PubMed ID: 20232407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells.
    Hisamatsu T; Suzuki M; Reinecker HC; Nadeau WJ; McCormick BA; Podolsky DK
    Gastroenterology; 2003 Apr; 124(4):993-1000. PubMed ID: 12671896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of human enteric α-defensins by NOD2 in the Paneth cell lineage.
    Tan G; Zeng B; Zhi FC
    Eur J Cell Biol; 2015 Jan; 94(1):60-6. PubMed ID: 25433720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing.
    Maeda S; Hsu LC; Liu H; Bankston LA; Iimura M; Kagnoff MF; Eckmann L; Karin M
    Science; 2005 Feb; 307(5710):734-8. PubMed ID: 15692052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease.
    van Heel DA; Ghosh S; Butler M; Hunt KA; Lundberg AM; Ahmad T; McGovern DP; Onnie C; Negoro K; Goldthorpe S; Foxwell BM; Mathew CG; Forbes A; Jewell DP; Playford RJ
    Lancet; 2005 May 21-27; 365(9473):1794-6. PubMed ID: 15910952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DMBT1 is a novel gene induced by IL-22 in ulcerative colitis.
    Fukui H; Sekikawa A; Tanaka H; Fujimori Y; Katake Y; Fujii S; Ichikawa K; Tomita S; Imura J; Chiba T; Fujimori T
    Inflamm Bowel Dis; 2011 May; 17(5):1177-88. PubMed ID: 20824812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation.
    Gutierrez O; Pipaon C; Inohara N; Fontalba A; Ogura Y; Prosper F; Nunez G; Fernandez-Luna JL
    J Biol Chem; 2002 Nov; 277(44):41701-5. PubMed ID: 12194982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muramyldipeptide modulates CXCL-8 release of BEAS-2B cells via NOD2.
    Farkas L; Stoelcker B; Jentsch N; Heitzer S; Pfeifer M; Schulz C
    Scand J Immunol; 2008 Sep; 68(3):315-22. PubMed ID: 18647246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.